← Back to Clinical Trials
Recruiting NCT07505875

NCT07505875 Pre-implementation Study to Develop Trans-tailored Services for Transgender Persons in Relation to chemsEX

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07505875
Status Recruiting
Phase —
Sponsor Institute of HIV Research and Innovation Foundation, Thailand
Condition Substance Use
Study Type OBSERVATIONAL
Enrollment 50 participants
Start Date 2024-05-01
Primary Completion 2026-12-01

Trial Parameters

Condition Substance Use
Sponsor Institute of HIV Research and Innovation Foundation, Thailand
Study Type OBSERVATIONAL
Phase N/A
Enrollment 50
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2024-05-01
Completion 2026-12-01
Interventions
Understanding of chemsex patterns, impacts, and service needs among transgender persons

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The study is a pre-implementation cross-sectional study exploring chemsex behaviors among transgender persons and gathering perspectives from multiple stakeholders to inform the development of transgender-tailored harm reduction services.

Eligibility Criteria

Inclusion Criteria: * Age ≥18 years * Able to communicate in Thai * Provide informed consent Exclusion Criteria: • Unable to participate in in-depth interview (IDI) (online or onsite)

Related Trials

VIEW ON CLINICALTRIALS.GOV ↗ MORE SUBSTANCE USE TRIALS
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology